-Member Login

Forgot your USERNAME OR PASSWORD?

Let's Stay Connected

Find us on the popular social networks

Facebook Twitter LinkedIn Flicker
  • About the Division

    The Division for Drug Discovery and Development (DDD) serves to help its members teach, present and discuss the critical role of pharmacology in all phases of the drug discovery, development and registration process. The process encompasses, but is not limited to; target discovery and validation, medicinal chemistry, combinatorial chemistry, molecular modeling and drug design, structure-pharmacological function relationships, functional genomics and proteomics, high throughput screening, identification and development of natural products, nutraceuticals, pharmacokinetics and pharmacodynamics, clinical testing and drug regulation/registration, clinical contracting and pharmacoepidemiology and pharmacoeconomics.



    Division News

  • 2017 ASPET Election Results

    The 2017 ASPET election closed on February 10, 2017 with a great turnout. Congratulations to the new Council members, division chairs, and division secretary-treasurers.

    2016 Drug Discovery and Development Award Winners
    Congratulations to the winners of the 2016 best presentation competition (poster session) at EB2016.
    Division Meetings and Activities

    The ASPET Annual Meeting site has all the details on division meetings and activities, including the business meeting for each division. Agendas are now available for download for the business meetings.

    2016 Division for Drug Discovery and Development Election Results

    Dr. Timothy A. Esbenshade, Project Director/Sr. Principal Research Scientist, Global Research and Development, AbbVie has been elected chair-elect of the division. Dr. Tom J. Parry, Senior Director, Pharmacology and Safety, Research and Development, Acorda Therapeutics, Inc. has been elected secretary/treasurer-elect of the division.

  • Division Goals

     

    • To help its members teach, present and discuss the critical role of pharmacology in all phases of the drug discovery, development and registration process.
    •  
    • To increase communication among researchers participating in various phases of the drug discovery, development and registration process.
    •  
    • To sponsor symposia and/or colloquia on timely, related topics at annual meetings.
    •  
    • To provide special venues at these meetings for graduate students and post-doctoral fellows with related research activities and interests to present and discuss their work in a relaxed, social setting with other students, fellows and the Division for Drug Discovery and Development members.